Leqembi Isn't Enough To Save Biogen Momentum (Rating Downgrade)
Source: SeekingAlpha
2026-05-26 08:11:55 ET
Last time I wrote about Biogen Inc. ( BIIB ) was at the end of 2025 , in the article " Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge ."...
Read the full article on Seeking Alpha
For further details see:
Leqembi Isn't Enough To Save Biogen Momentum (Rating Downgrade)
PTC Therapeutics Inc.
NASDAQ: PTCT
PTCT Trading
2.13% G/L:
$71.91 Last:
245,245 Volume:
$70.78 Open:
PTCT Latest News
May 07, 2026 04:01:00 pm
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
PTCT Stock Data
$5,800,830,036
75,872,448
1.06%
134
N/A
Biotechnology & Life Sciences
Healthcare
US
Warren
